(Corrects spelling of name in second paragraph.)
Oct. 19 (Bloomberg) -- Sanofi has experienced a “significant volume increase” in drug sales in China, Chief Executive Officer Chris Viehbacher said in an interview in Beijing today.
The company is able to borrow at “extremely low rates” at the moment, Viehbacher told Bloomberg TV.
To contact the reporter on this story: Daryl Loo in Beijing at firstname.lastname@example.org
To contact the editor responsible for this story: Nicholas Wadhams at email@example.com